A detailed history of Twinbeech Capital LP transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 114,531 shares of TMCI stock, worth $797,135. This represents 0.01% of its overall portfolio holdings.

Number of Shares
114,531
Holding current value
$797,135
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $8.45 $573,800 - $967,786
114,531 New
114,531 $664,000
Q2 2022

Aug 15, 2022

BUY
$12.93 - $20.29 $95,268 - $149,496
7,368 Added 41.32%
25,199 $361,000
Q1 2022

May 16, 2022

BUY
$16.73 - $21.58 $298,312 - $384,792
17,831 New
17,831 $337,000

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $386M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.